peritoneal injections at 10 day intervals with a vaccine prepared from the brains, lungs, livers, spleens, and kidneys of mice very sick from intravenous injection with virus. These 9 mice developed typical tremors and convulsions on the 6th or 7th day after the intracerebral test injection but recovered, while 14 control mice died in typical convulsions.
The experiments to be reported here are concerned chiefly with the cause for the failure of heterologous vaccines to immunize guinea pigs, the immunizing power of homologous vaccines in relation to their virus content prior to formolization, and the mechanism of the immunity produced in guinea pigs by inactive virus in comparison with that which follows an infection (1) .
Methods and Materials Preparation of Vaccines.--The guinea pigs furnishing the tissue for vaccines
were killed when very sick or moribund after pad or intracerebral injection with highly virulent guinea pig passage virus (1) . The organs used were removed without delay and ground very finely in a tissue grinder. Enough saline was added to make a 20 per cent suspension by weight. In the earlier experiments the suspensions were filtered through several layers of gauze, but later the filtration was omitted because it was found not to be necessary, provided the tissue was ground very finely. In experiments in which the tissue suspensions were titrated a small portion of the suspension was removed for this purpose soon after grinding. To the remainder of the suspension a sufficient amount of neutral formalin was added to make the final concentration of formalin 1 per cent (0.37 per cent formaldehyde) by volume. The vaccines contained in 50, 100, or 200 cc. Erlenmeyer flasks closed with rubber stoppers were vigorously shaken for a few minutes and then kept in a dark place in the laboratory for 2 days. Thereafter they were stored in the refrigerator for the periods of time indicated below in the text. The vaccine remaining after the removal of the amount needed for the first injection was transferred to test tubes and covered with vaseline until used. Shortly before each injection the free formaldehyde in the vaccines was converted into urotropine by adding ammonium hydroxide until a faintly pink color was obtained with phenolphthalein as indicator. The colorimetric tests were carried out with a few drops of vaccine on a white porcelain plate commonly used for pH determinations according to the indicator method. The "neutralized" vaccine was then injected immediately by the routes indicated in the text. The majority of the guinea pigs to be vaccinated received 2 or 3 injections at 10 or 6 day intervals, because it had been found in previous experiments that repeated injections with vaccine usually conferred a stronger immunity than a single injection.
The vaccines were harmless to the animals, except in a few instances in which a toxic peritonitis resulted from intraperitoneal injections. Intramuscular injections were occasionally followed by a more or less marked induration at the site of inoculation. The formalin in the concentration used appeared to have a strongly bactericidal action in the case of vaccines prepared from diseased lung, which frequently contained bacteria that were harmful when the suspensions were injected without formalin. That the virus was completely inactivated in the vaccines is indicated by the fact that not one in over 200 guinea pigs injected developed evidence of infection. Furthermore, in many of the earlier experiments one or two extra guinea pigs were given excessively large doses of vaccine (0.2 cc. intracerebrally, 1 cc. in each hind pad, and 5 cc. intraperitoneally) without producing infection by such treatment. These animals were tested for circulating virus at different times after vaccination, with negative results in all cases.
The strongest evidence for the complete inactivation of the virus in the vaccines is the incomplete immunity produced by them in the majority of the guinea pigs, as will be shown later. This low grade of immunity is in sharp contrast to the very solid resistance induced by small amounts of virus even in guinea pigs which failed to show fever after the immunizing injection (1) .
Two experiments were performed to determine the effect of the two inactivating factors, formalin and room temperature, on the virus. In both tests the formalin alone was able to inactivate the virus in vaccines stored in the refrigerator for 9 days without previous incubation at room temperature. Storage for 2 days at room temperature without adding formalin to the vaccines inactivated the virus in one test, but not in the other.
Experimental Ani~nals.--The guinea pigs used weighed from 300 to 400 gm. in the majority of the experiments and were obtained from the Institute stock. The mice used for titrating tissue suspensions were 5 to 6 weeks of age and came from the Institute colony. Both the guinea pig and mouse stocks are free from choriomeningitis. Animals used in experiments on choriomeningitis are kept under isolation as a routine, and contact with infected animals is carefully avoided.
Tea of Immunity.--A mixture of two highly virulent guinea pig passage strains (1) was used to test the immunity of vaccinated guinea pigs. In the preliminary experiments control guinea pigs occasionally recovered from the severe disease induced by this virus. Its virulence increased, however, on successive passages until it killed all the control animals in 8 to 14 days after inoculation. The standard dose for the tests of immunity was 0.5 cc. of a 1 per cent guinea pig brain suspension injected in equal parts subcutaneously into the hind pads. This amount of suspension as a rule contained about 100,000 minimal infective doses of virus.
Vaccination of Guinea Pigs with Vaccines Prepared from Guinea Pig and Mouse Tissue
To confirm the results of the preliminary experiments, in which mouse tissue vaccines failed to immunize guinea pigs, while homologous vaccines produced immunity, two other series of vaccines of guinea pig or mouse origin were tested.
It proved difficult to obtain from each species vaccines of about equal virus content, even when mixtures of several organs were used. For this reason 10 -~ and 10 -2 dilutions of the vaccines were tested for immunizing power besides the undiluted material. Two mouse tissue vaccines (corresponding to guinea pig tissue vaccines 7 and 8, Table I ) had to be discarded because their virus content was inferior.
The vaccines with the corresponding numbers in Tables I and II were prepared, titrated, and injected at the same time, and the guinea pigs inoculated with them were tested for immunity with the same materials. Before formolization the tissue suspensions were titrated in guinea pigs by pad injection with 1 cc. of the decimal dilutions in saline of the vaccines, one animal being used for each dilution. The vaccines were stored at room temperature for 2 days and in the refrigerator for 8 days. The guinea pigs to be vaccinated were injected twice at an interval of 10 days with 1 cc. into each thigh and 2 cc. intraperitoneaUy, making a total of 8 cc. vaccine per guinea pig, Their immunity was tested 2 weeks after the second vaccination. Tables I and II shows that the undiluted guinea pig tissue vaccines produced immunity in every case and that some vaccines were also effective in a 10 -~ dilution, whereas the vaccines prepared from mouse tissue, with one exception, completely failed to immunize, even when their virus content before formolization was very high.
The summary of the results in
A comparison of the virus content of the guinea pig vaccines before formollzation with their immunizing power suggests a lack of parallelism between the two factors. The result obtained with guinea pig tissue vaccine 7 points in the same direction. In this case the tissue suspension was divided into two parts before formolization. One part was used as a whole, while the other part was centrifuged at 1600 to 1700 R.p.x~. for 10 minutes. Vaccines were prepared from the whole suspension as well as from the supernatant fluid. In spite of the fact that both materials gave the same titration end-point, the vaccine T A B L E I Brain, lung, heart, liver, spleen, kidney, suprarcnal: 0 ffi no detectable reaction to the test inoculation. -{-ffi fever, but no other signs of illness. q-q-ffi fever, slight symptoms and a slight loss of weight, followed by rapid recovery.
Vaccination of Guinea Pigs witk Vaccines Prepared from Guinea Pig Tissue
-{-q-q-= fever, severe symptoms with marked loss of weight, followed by slow recovery.
q--{--{--t-ffi died of choriomeningitis. * The q-sign indicates that the titration end-point was perhaps not reached at this dilution.
r~-tYNIT¥ TO LYMPHOCYTIC CHORIOMENINGITIS made from the whole suspension had a greater immunizing power than that from the supernatant liquid.
Inhibition of the Immunity by Injecting Formolized Normal Mouse Tissue Together with the Guinea Pig Tissue Vaccines
The following experiments were performed in an attempt to determine the cause for the failure of heterologous vaccines to immunize guinea pigs. Laidlaw and Dunkin (2) also failed with dog distemper and attributed the phenomenon to the clogging of the immunity mechanism by heterologous antigens. This appeared to be a reasonable explanation, but direct experimental evidence for it was lacking. It was therefore decided to add formolized normal mouse tissue to the guinea pig tissue vaccines or to inject it simultaneously with them, in order to determine its effect on their immunizing power.
In the experiments of the first series (Table III) the vaccines and the formolized normal mouse tissue suspensions were mixed (2 parts to 1) shortly before inoculation. One group of guinea pigs received the tissue mixture, and another group the vaccine mixed with a corresponding amount of saline. In the experiments of the second series (Table IV) the vaccine and the normal mouse tissue were injected either by different routes (vaccine 5) or by the same route but on opposite sides of the body (vaccines 6 to 11). Saline inoculations were omitted. The vaccines and the corresponding suspensions of normal mouse tissue prepared from the same organs and in the same manner as the vaccines were kept at room temperature for 2 days and in the refrigerator for 7 to 14 days prior to injection. Ammonium hydroxide was added to the mouse tissue suspensions in the same manner as to the vaccines before the materials were mixed, and the mixtures were inoculated a few minutes after mixing. The tissue constituents, the dosage, and the routes of inoculation are indicated in the tables. The guinea pigs were tested for immunity in the usual manner 2 to 3 weeks after the last injection of vaccine.
The results presented in Tables III and IV show that the heterologous normal tissue inhibited the immunity in a certain number of cases. The inhibitory effect was generally more marked when the materials were mixed before injection than when they were inoculated simultaneously on opposite sides of the body. In the one comparative experiment (vaccine 5) the same result was obtained with both methods. As in previous tests, lung vaccines proved superior to vaccines prepared from brain or liver.
The Immunizing Power of Guinea Pig Tissue Vaccines in Relation to Their Virus Content before Formolisation
Since the results of the experiments recorded in Table I suggested a lack of parallelism between the virus content of vaccines prepared from guinea pig tissues and their immunizing properties, another series of similar experiments was carried out, in which the titration end-points of the suspensions used for vaccines were more accurately determined. In order to eliminate any interference by bacterial antigens, lung vaccines were not used and the tissues selected were free from cultivable organisms.
The tissue suspensions from which the vaccines were made were titrated immediately after grinding by intracerebral injection of mice with 0.05 × 10 -a to 0.05 × 10 -7 cc., 3 mice being used for each dilution in saline. The vaccines were formolized as usual and stored for 2 days at room temperature and for 7 clays in the refrigerator. Guinea pigs were vaccinated by 3 intraperitoneal injections at 6 day intervals with 2 cc. undiluted or diluted vaccine, as indicated in Table V , and tested for ~mmunity 15 days after the last vaccination.
The results recorded in Table V show that the immunizing power of the vaccines did not parallel their content of active virus prior to formolization. In the first experiment, 3 vaccines prepared from different tissues of the same animals were compared. The vaccines prepared from the liver, heart, and spleen tissue were inferior to the brain vaccine in spite of the fact that the heart and spleen suspensions probably contained as much virus as the brain suspension and the liver suspension contained more. Since the results obtained with these three vaccines may not be strictly comparable because of their different tissue constituents, the vaccines in the following experiments were all prepared from brain. A comparison of their immunizing properties shows clearly that they did not correspond to the virus content of the suspensions. This was particularly striking in the 3rd experiment, in which the vaccine prepared from brain removed during the earlier stage of the disease was richer in virus but poorer in immunizing substance than the vaccine made from brain obtained from moribund animals.
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Experiments Bearing on the Mechanism of the Immunity Induced by Formolized Tissue Vaccines
The following experiments were undertaken in an attempt to determine first, whether prolonged treatment with large amounts of homologous vaccine would lead to a high degree of immunity and, second, whether protective serum antibodies could be produced by such treatment. In previous tests the sera of guinea pigs vaccinated in the usual manner (by 2 or 3 vaccine injections) failed to have any neutralizing effect on the virus, although the guinea pigs were immune.
Sera drawn on the 10th day after the test of immunity as a rule had protective properties. In 2 out of 10 such sera virus and antibodies were present at the same time, that is, the sera were virulent on intracerebral inoculation but failed to infect, and even neutralized about 10 a*.I.D, of virus added to them, when injected into the pads. This rather rapid appearance of the antibodies is in contrast to the relatively slow formation of antivirus in unvaccinated guinea pigs after injection with virus (1). Their serum usually contained no demonstrable antibody on the 10th day after inoculation. It is possible, therefore, that the vaccination causes the production of a very small amount of antibody not demonstrable by the usual neutralization test, and that the antibody production is enhanced by inoculation with active virus.
The vaccines used for the "hyperimmunization" of guinea pigs were prepared from the lungs, liver, brain, heart, spleen, kidneys, or suprarenals of guinea pigs moribund after pad injection with virus. The suprarenal vaccines were 10 per cent suspensions by weight, while all the other vaccines were 20 per cent suspensions. They were incubated at room temperature for 2 days and then stored in the refrigerator for 7 to 14 days. Guinea pigs weighing from 500 to 600 gin. were given alternating intraperitoneal, intramuscular, and subcutaneous injections at 5 to 7 day intervals with varying large doses depending on the amount of vaccine available at the time of inoculation. The number of injections and the total amount of vaccine given are recorded in Table VI . The immunity was tested as usual on the 17th day after the last vaccination. 2 days before the test of immunity 10 cc. of heart blood were taken from each animal in order to obtain serum for protection tests. Table VI shows that 4 of the 9 guinea pigs vaccinated became so highly immune that they showed no reaction to the test inoculation which was fatal in all 9 controls. The degree of immunity in these 4 animals, therefore, compares favorably with that of guinea pigs that have gone through an infection (1).
TABLE VI
Hyperiramunizagon of Guinea Pigs with Vaccines Prepared from Guinea Pig Tissue
The remaining guinea pigs showed a moderate fever which was of shorter duration than in guinea pigs vaccinated in the ordinary manner. There was practically no loss of weight or condition in all the animals. Some of the guinea pigs that showed fever carried traces of virus in the blood during the febrile period, while in the 4 guinea pigs without reaction no circulating virus was detected on the 6th and 8th days after the test of immunity. The tests for virus were made by injecting normal guinea pigs intracerebrally with 0.25 cc. heart blood of the vaccinated animals.
The sera obtained from the 9 guinea pigs were pooled, and the mixture was tested for protective antibodies by neutralization and protection tests in guinea pigs. In the neutralization tests the mixtures of serum (0.25 cc.) and virus (0.25 cc.) incubated for ~ hour at room temperature were injected into the pads of guinea pigs as described before (3). The results of the tests presented in Table  VII show that the immune serum neutralized approximately one minimal lethal dose (~.L.D.) of virus. The first protection test in which 2 guinea pigs weighing 450 to 500 gm. received 1 cc. of the pooled immune serum intravenously ~ hour before pad injection with 1 to 10 M.L.V. of virus gave a negative result. The test was therefore repeated using larger amounts of serum. A guinea pig was given 3 cc. serum intravenously ½ hour before a similar virus inoculation, and 4 cc. by the same route 5 days l~ter. The animal developed comparatively mild, non-fatal choriomeningitis, while the 2 control animals not treated with serum died. In the next experiment still larger amounts of serum were used. Two guinea pigs received 5 cc. immune serum intravenously 2 hours before pad inoculation with about 105 g.L.V, of virus, 5 cc. serum intravenously on the 5th day, and 4 cc. intracardiallyon the 8th day after the virus inoculation. One of these 2 animals showed fever, but no other definite signs of illness, while the other developed mild choriomeningitis followed by quick recovery. The 2 untreated controls died of choriomeningitis.
These tests indicate that the formolized vaccines, when administered in large amounts, can give rise to protective antibodies, whose concentration, however, is rather low in view of the considerable degree of immunity acquired by the donor animals.
DISCUSSION
The vaccines used in the experiments reported are considered to contain completely inactive virus because of the rigorous treatment given to them, the consistent absence of symptoms in vaccinated animals, and the failure to detect circulating virus in vaccinated guinea pigs. It is possible that a lower concentration of formalin would have sufficed to inactivate the virus and permitted the production of more effective vaccines, but in such a case one could not be certain that one was always dealing with a completely inactive agent. The degree of immunity produced by the vaccines used is far inferior to that induced by modified active virus (1), which immunizes guinea pigs solidly even in cases in which they show no detectable reaction to the virus inoculation.
The inhibition of the immunity by adding formolized normal mouse tissue to the guinea pig tissue vaccines supports the suggestion of Laidlaw and Dunkin (2) that the failure of heterologous vaccines to immunize is due to the clogging of the immunity mechanism by heterologous antigens. Since the ingredients were treated alike before mixing, it is unlikely that the decrease in immunizing power in the mixtures was caused by chemical reactions between their constituents, altering the antigenic properties of the vaccines. The fact that the inhibition of the immunity was more pronounced when the materials were mixed before inoculation than when they were injected simultaneously on opposite sides of the body can be explained by assuming that the clogging process is mainly a mechanical phenomenon, which is most marked when the different antigens reach the same receptive tissues at the same time.
The lack of parallelism between the virus content of homologous vaccines prior to formolization and their immunizing power cannot be satisfactorily explained. One might assume either that compounds of the virus, devoid of infectivity but still antigenic, are formed in the infected tissues, or that non-infectious split products of the virus take part in the immunization.
In view of the high degree of immunity and the protective antibodies produced by prolonged treatment with large doses of formolized vaccine there is at present no good reason to suppose that the mechanism of the immunity induced by inactive virus differs fundamentally from that of the immunity which follows an infection. The differences seem to be quantitative rather than qualitative.
SI)~MARY
Guinea pigs can be immunized against lymphocytic choHomeningitis by 2 or 3 injections with formolized vaccines prepared from a variety of infected guinca pig tissues. Vaccines prepared from the consolldated areas of diseased lungs gave the best results. The immunity produced was partial in the majority of the cases, in that the vaccinated animals as a rule showed fever after the test of immunity and virus was present in the circulation during the febrile period.
Vaccines prepared from infected mouse tissue had no, or very little, immunizing power for guinea pigs, even when prior to formolization they contained at least as much virus as guinea pig tissue vaccines. This failure to immunize appears to be due to the interference by heterologous antigens, since the immunity induced by homologous vaccines was often inhibited when formolized normal mouse tissue suspensions treated in the same manner as the guinea pig tissue vaccines were added to the latter before inoculation. The inhibitory effect of the heterologous tissue was less marked when it was not mixed with the vaccine but injected simultaneously on the opposite side of the body.
The immunizing power of homologous vaccines did not parallcl their virus content prior to formolization.
A high degree of immunity, characterized by protective antibodies in the serum, was produced in some guinea pigs by prolonged treatment with large doses of homologous vaccine, while sera of guinea pigs vaccinated in the ordinary manner contained no detectable neutralizing antibodies. It is possible, therefore, that the immunity
